Author:
Li Shihai,Xu Zili,Guo Mingkun,Li Menglong,Wen Zhining
Funder
National Natural Science Foundation of China
Subject
Drug Discovery,Pharmacology
Reference30 articles.
1. Drug-induced prolongation of the QT interval;Roden;N Engl J Med,2004
2. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges;Wilke;Nat Rev Drug Discov,2007
3. The impact of drug-induced QT interval prolongation on drug discovery and development;Fermini;Nat Rev Drug Discov,2003
4. Assessing cardiovascular drug safety for clinical decision-making;Woosley;Nat Rev Cardiol,2013
5. ICH. E14 Clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. www.ema.europa.eu/en/ich-e14-clinical-evaluation-qtqtc-interval-prolongation-proarrhythmic-potential-non-antiarrhythmic [accessed October 19, 2021].
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献